ERDAFITINIB

ERDAFITINIB was reported 1247 times

ERDAFITINIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MET GENE AMPLIFICATION 1 0.1667
1 NAIL PTERYGIUM 1 0.0769
2 URETHRAL CANCER METASTATIC 1 0.0625
3 BRONCHIAL ASPIRATION PROCEDURE 1 0.0556
4 BLOOD PHOSPHORUS 1 0.0526
5 NAIL TOXICITY 15 0.0500
6 SCROTUM EROSION 1 0.0500
7 GENITAL DRYNESS 1 0.0400
8 ONYCHOLYSIS 58 0.0371
9 BLOOD ZINC INCREASED 1 0.0333
10 NAIL DISCOMFORT 4 0.0331
11 SCROTAL DERMATITIS 2 0.0317
12 ANTISYNTHETASE SYNDROME 5 0.0278
13 CORNEAL EPITHELIOPATHY 1 0.0263
14 GASTRIC HYPERMOTILITY 1 0.0250
15 HYPERPHOSPHATAEMIA 53 0.0246
16 TRICHOMEGALY 1 0.0227
17 INAPPROPRIATE RELEASE OF PRODUCT FOR DISTRIBUTION 1 0.0208
18 ENDOMETRIAL STROMAL SARCOMA 1 0.0200
19 SEROUS RETINOPATHY 2 0.0190
20 HYPERGEUSIA 1 0.0169
21 TRANSAMINASES 1 0.0169
22 CUTANEOUS CALCIFICATION 3 0.0164
23 OCULAR TOXICITY 18 0.0163
24 NAIL DEFORMATION 1 0.0149
25 MALIGNANT NEOPLASM OF RENAL PELVIS 2 0.0146
26 TRANSITIONAL CELL CARCINOMA 18 0.0139
27 LUNG SQUAMOUS CELL CARCINOMA METASTATIC 1 0.0135
28 FINGERPRINT LOSS 2 0.0123
29 EPIPHYSIOLYSIS 3 0.0120
30 SEROUS RETINAL DETACHMENT 10 0.0119
31 CORNEAL THINNING 3 0.0117
32 NAIL DISCOLOURATION 45 0.0114
33 BLOOD PHOSPHORUS INCREASED 28 0.0102
34 EAR DRYNESS 1 0.0095
35 ANAL EROSION 1 0.0091
36 NEPHROSTOMY 3 0.0091
37 ONYCHOMADESIS 38 0.0090
38 PARANASAL SINUS HAEMORRHAGE 1 0.0090
39 CORNEAL TOXICITY 1 0.0090
40 NAIL BED BLEEDING 5 0.0088
41 NAIL BED TENDERNESS 1 0.0088
42 TRANSITIONAL CELL CARCINOMA METASTATIC 1 0.0085
43 METASTATIC CARCINOMA OF THE BLADDER 3 0.0085
44 URINARY CYSTECTOMY 1 0.0085
45 NAIL BED INFECTION 2 0.0084
46 DERMATOPHYTOSIS OF NAIL 1 0.0084
47 MACULAR DETACHMENT 2 0.0083
48 LACRIMATION DISORDER 1 0.0082
49 ONYCHOMALACIA 1 0.0080
50 ONYCHALGIA 8 0.0080
51 CORNEAL DEFECT 1 0.0076
52 XERODERMA 2 0.0075
53 NAIL DYSTROPHY 4 0.0071
54 OESOPHAGOGASTRODUODENOSCOPY 1 0.0071
55 EPENDYMOMA 1 0.0069
56 HEPATIC ENZYME 1 0.0067
57 MUCOCUTANEOUS RASH 1 0.0065
58 BLOOD PHOSPHORUS ABNORMAL 3 0.0064
59 CHORIORETINOPATHY 9 0.0063
60 ENDOMETRIAL CANCER METASTATIC 1 0.0062
61 KERATITIS BACTERIAL 1 0.0061
62 NAIL DISORDER 53 0.0061
63 SCROTAL ERYTHEMA 1 0.0060
64 LIP SQUAMOUS CELL CARCINOMA 1 0.0060
65 DECREASED GAIT VELOCITY 1 0.0060
66 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 5 0.0056
67 METASTASES TO MUSCLE 1 0.0055
68 XEROPHTHALMIA 3 0.0051
69 STENT REMOVAL 1 0.0051
70 GENITAL TRACT INFLAMMATION 1 0.0050
71 URETERIC CANCER 2 0.0050
72 RETINAL DEPOSITS 1 0.0049
73 NAIL BED DISORDER 2 0.0047
74 PORTAL FIBROSIS 1 0.0047
75 GROWTH ACCELERATED 1 0.0046
76 NAIL AVULSION 1 0.0044
77 CENTRAL SEROUS CHORIORETINOPATHY 3 0.0044
78 CALCIPHYLAXIS 8 0.0044
79 SEVERE CUTANEOUS ADVERSE REACTION 1 0.0042
80 NAIL INFECTION 6 0.0042
81 PARONYCHIA 18 0.0041
82 LEUKOPLAKIA 1 0.0041
83 BODY HEIGHT INCREASED 2 0.0041
84 PLANTAR ERYTHEMA 1 0.0040
85 SCROTAL ULCER 1 0.0038
86 NAIL RIDGING 2 0.0038
87 KYPHOSCOLIOSIS 1 0.0038
88 SUBRETINAL FLUID 4 0.0037
89 ENTEROCOLITIS BACTERIAL 1 0.0036
90 RETINAL DEPIGMENTATION 1 0.0033
91 SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG 1 0.0033
92 DRY GANGRENE 2 0.0031
93 NAIL BED INFLAMMATION 1 0.0031
94 PIK3CA-ACTIVATED MUTATION 1 0.0030
95 PULMONARY NECROSIS 1 0.0029
96 PELVIC NEOPLASM 1 0.0029
97 LORDOSIS 1 0.0028
98 OBSTRUCTIVE PANCREATITIS 2 0.0026
99 RETINAL OEDEMA 5 0.0026
100 RETINAL DETACHMENT 24 0.0026
101 ULCERATIVE KERATITIS 7 0.0026
102 ANHIDROSIS 1 0.0025
103 BLOOD URIC ACID ABNORMAL 1 0.0025
104 METASTATIC NEOPLASM 10 0.0023
105 VULVOVAGINAL MYCOTIC INFECTION 9 0.0023
106 CHRONIC CUTANEOUS LUPUS ERYTHEMATOSUS 1 0.0022
107 ARTHRITIS BACTERIAL 9 0.0022
108 SALIVARY GLAND CANCER 1 0.0020
109 SCAPULA FRACTURE 1 0.0019
110 SCIATIC NERVE NEUROPATHY 1 0.0019
111 CORNEAL EROSION 1 0.0019
112 SCROTAL PAIN 1 0.0019
113 CORNEAL DISORDER 4 0.0018
114 ONYCHOCLASIS 12 0.0017
115 HAIR GROWTH ABNORMAL 12 0.0017
116 CORNEAL EPITHELIUM DEFECT 1 0.0017
117 NASAL MUCOSAL DISORDER 1 0.0017
118 XEROSIS 2 0.0016
119 HEPATOBILIARY DISEASE 1 0.0016
120 METASTASES TO PELVIS 1 0.0016
121 GASTRIC NEOPLASM 1 0.0016
122 ACTIVITIES OF DAILY LIVING DECREASED 1 0.0016
123 CHORIORETINITIS 1 0.0016
124 DACRYOSTENOSIS ACQUIRED 2 0.0015
125 NASAL CRUSTING 1 0.0015
126 COUNTERFEIT PRODUCT ADMINISTERED 2 0.0015
127 GINGIVAL DISCOMFORT 1 0.0015
128 MUCOSAL DRYNESS 3 0.0015
129 TASTE DISORDER 30 0.0015
130 EFFUSION 2 0.0015
131 CUTANEOUS SYMPTOM 1 0.0015
132 MUCOSAL INFLAMMATION 38 0.0014
133 ANGULAR CHEILITIS 1 0.0014
134 NUTRITIONAL CONDITION ABNORMAL 1 0.0014
135 SJS-TEN OVERLAP 1 0.0014
136 MACULOPATHY 5 0.0014
137 PALMOPLANTAR KERATODERMA 1 0.0014
138 STOMATITIS 82 0.0014
139 LIMB ASYMMETRY 1 0.0013
140 RETINAL INJURY 1 0.0013
141 OBSTRUCTION 5 0.0013
142 THYROID HORMONES DECREASED 1 0.0013
143 SKIN TOXICITY 7 0.0012
144 PERITONSILLAR ABSCESS 1 0.0012
145 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 27 0.0012
146 RETINITIS 2 0.0012
147 GENITAL BURNING SENSATION 1 0.0012
148 BLOOD MAGNESIUM INCREASED 1 0.0011
149 BONE CONTUSION 1 0.0011
150 PUNCTATE KERATITIS 1 0.0011
151 TEMPORAL ARTERITIS 1 0.0011
152 DENTAL CARE 2 0.0011
153 RETINOPATHY 4 0.0011
154 HYPERMETROPIA 1 0.0011
155 TUMOUR HAEMORRHAGE 3 0.0011
156 LIP PAIN 3 0.0010
157 PURULENCE 2 0.0010
158 HYPOGEUSIA 2 0.0010
159 NASAL INFLAMMATION 1 0.0009
160 TONGUE DISCOMFORT 4 0.0009
161 VASCULAR CALCIFICATION 1 0.0009
162 SUPERFICIAL INJURY OF EYE 1 0.0009
163 PNEUMONIA STREPTOCOCCAL 1 0.0009
164 NAIL GROWTH ABNORMAL 1 0.0009
165 TONGUE ULCERATION 3 0.0009
166 EYE DISORDER 29 0.0009
167 MUCOSAL HAEMORRHAGE 1 0.0009
168 DRY EYE 43 0.0009
169 EPIDIDYMITIS 1 0.0009
170 HYPORESPONSIVE TO STIMULI 1 0.0009
171 GASTROINTESTINAL TOXICITY 4 0.0008
172 HAEMATOLOGICAL INFECTION 2 0.0008
173 AORTIC VALVE REPLACEMENT 1 0.0008
174 HAEMORRHAGE URINARY TRACT 2 0.0008
175 PHYSICAL DECONDITIONING 2 0.0008
176 HERPES OPHTHALMIC 1 0.0008
177 LIP BLISTER 2 0.0007
178 SKIN DEPIGMENTATION 1 0.0007
179 INTESTINAL MASS 1 0.0007
180 ORAL FUNGAL INFECTION 2 0.0007
181 PERIPHERAL ARTERY OCCLUSION 1 0.0007
182 NONINFECTIVE GINGIVITIS 1 0.0007
183 PULMONARY SEPSIS 1 0.0007
184 ONYCHOMYCOSIS 3 0.0007
185 ORAL CANDIDIASIS 9 0.0007
186 SUPERINFECTION 1 0.0007
187 ATRIOVENTRICULAR BLOCK SECOND DEGREE 2 0.0007
188 KERATITIS 2 0.0007
189 HEAT STROKE 1 0.0007
190 NASAL ULCER 1 0.0006
191 HEPATIC NEOPLASM 2 0.0006
192 BLOOD CALCIUM ABNORMAL 1 0.0006
193 RETINAL THICKENING 1 0.0006
194 CACHEXIA 3 0.0006
195 SKIN NECROSIS 3 0.0006
196 EXTREMITY NECROSIS 1 0.0006
197 DRY MOUTH 46 0.0006
198 KYPHOSIS 1 0.0006
199 OSTEOMYELITIS 10 0.0006
200 METAMORPHOPSIA 1 0.0005
201 HYPERTRICHOSIS 1 0.0005
202 BILE DUCT OBSTRUCTION 1 0.0005
203 MYELOPATHY 1 0.0005
204 LYMPHADENOPATHY MEDIASTINAL 1 0.0005
205 SPINAL CORD COMPRESSION 2 0.0005
206 ADRENOCORTICAL INSUFFICIENCY ACUTE 1 0.0005
207 PYELONEPHRITIS ACUTE 1 0.0005
208 GENE MUTATION 1 0.0005
209 CELL DEATH 1 0.0005
210 MUSCLE CONTRACTURE 1 0.0005
211 CATARACT 29 0.0005
212 ATRIAL THROMBOSIS 1 0.0005
213 EYE DISCHARGE 5 0.0005
214 URINARY BLADDER HAEMORRHAGE 1 0.0005
215 SLEEP DEFICIT 1 0.0005
216 EAR SWELLING 1 0.0005
217 RENAL NEOPLASM 1 0.0005
218 ABNORMAL SENSATION IN EYE 2 0.0005
219 LACRIMATION INCREASED 14 0.0005
220 PERIODONTITIS 1 0.0005
221 CHAPPED LIPS 2 0.0005
222 PRODUCT LOT NUMBER ISSUE 1 0.0005
223 CALCINOSIS 1 0.0004
224 ORAL PAIN 10 0.0004
225 CORNEAL OEDEMA 1 0.0004
226 RENAL COLIC 1 0.0004
227 TIBIA FRACTURE 2 0.0004
228 INGROWING NAIL 1 0.0004
229 URINARY TRACT OBSTRUCTION 1 0.0004
230 METASTASIS 3 0.0004
231 GASTROINTESTINAL OBSTRUCTION 1 0.0004
232 EYE OEDEMA 1 0.0004
233 HYPOPHOSPHATAEMIA 3 0.0004
234 AGEUSIA 10 0.0004
235 OSTEITIS 1 0.0004
236 METASTASES TO PERITONEUM 1 0.0004
237 ANGLE CLOSURE GLAUCOMA 1 0.0004
238 ILEOSTOMY 1 0.0004
239 CANCER PAIN 1 0.0004
240 METASTASES TO CENTRAL NERVOUS SYSTEM 5 0.0004
241 THERAPY PARTIAL RESPONDER 6 0.0004
242 RETINAL DISORDER 1 0.0004
243 NASAL DISORDER 1 0.0004
244 BLOOD POTASSIUM ABNORMAL 1 0.0004
245 GASTRIC PERFORATION 1 0.0004
246 HYPERAESTHESIA 3 0.0004
247 TENOSYNOVITIS 1 0.0004
248 ORAL DISCOMFORT 5 0.0004
249 SKIN FISSURES 7 0.0004
250 MACULAR OEDEMA 2 0.0004
251 ADVERSE DRUG REACTION 32 0.0004
252 DRUG TOLERANCE DECREASED 1 0.0004
253 SKIN HYPERTROPHY 1 0.0004
254 DISEASE PROGRESSION 42 0.0004
255 NECK MASS 1 0.0004
256 DUODENAL ULCER HAEMORRHAGE 1 0.0003
257 NEOPLASM 4 0.0003
258 PHARYNGEAL DISORDER 1 0.0003
259 MOUTH ULCERATION 7 0.0003
260 EMERGENCY CARE 1 0.0003
261 DYSAESTHESIA 1 0.0003
262 HYPERCALCAEMIA 4 0.0003
263 SCOLIOSIS 2 0.0003
264 BLOOD BLISTER 1 0.0003
265 NASAL DRYNESS 2 0.0003
266 PAIN IN JAW 9 0.0003
267 DEATH 272 0.0003
268 HEPATOTOXICITY 7 0.0003
269 LIVER ABSCESS 1 0.0003
270 THERAPY CHANGE 3 0.0003
271 LISTLESS 1 0.0003
272 ADVERSE REACTION 4 0.0003
273 SKIN INJURY 1 0.0003
274 METASTASES TO SPINE 1 0.0003
275 FEEDING DISORDER 6 0.0003
276 DRY THROAT 3 0.0003
277 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
278 PRODUCT LABEL ISSUE 2 0.0003
279 PRODUCT PRESCRIBING ERROR 7 0.0003
280 PNEUMONITIS 8 0.0003
281 THERAPY CESSATION 15 0.0003
282 LARGE INTESTINE PERFORATION 2 0.0003
283 AORTIC STENOSIS 1 0.0003
284 METASTASES TO LIVER 5 0.0003
285 BLOOD ALKALINE PHOSPHATASE INCREASED 7 0.0003
286 MOUTH HAEMORRHAGE 2 0.0003
287 SKIN DISORDER 9 0.0003
288 LOSS OF CONTROL OF LEGS 1 0.0003
289 SCAB 3 0.0003
290 DRY SKIN 35 0.0003
291 PARANASAL SINUS HYPERSECRETION 1 0.0003
292 CLAVICLE FRACTURE 1 0.0003
293 GINGIVAL DISORDER 1 0.0003
294 APHTHOUS ULCER 2 0.0003
295 HYPOALBUMINAEMIA 2 0.0003
296 FAECES HARD 1 0.0003
297 SKIN ODOUR ABNORMAL 1 0.0003
298 IDIOPATHIC PULMONARY FIBROSIS 1 0.0003
299 NEUROPATHY PERIPHERAL 24 0.0003
300 HYPERPHAGIA 1 0.0003
301 AZOTAEMIA 1 0.0003
302 PERIPHERAL ISCHAEMIA 1 0.0002
303 TRIGGER FINGER 1 0.0002
304 HAIR COLOUR CHANGES 3 0.0002
305 VISUAL ACUITY REDUCED 8 0.0002
306 EMBOLISM 2 0.0002
307 LIVER FUNCTION TEST INCREASED 5 0.0002
308 HORDEOLUM 1 0.0002
309 URINE OUTPUT DECREASED 2 0.0002
310 ADVERSE EVENT 21 0.0002
311 LYMPHOCYTE COUNT DECREASED 4 0.0002
312 ILEUS PARALYTIC 1 0.0002
313 BRAIN NEOPLASM MALIGNANT 1 0.0002
314 URINARY TRACT DISORDER 1 0.0002
315 OEDEMA 12 0.0002
316 BLOOD THYROID STIMULATING HORMONE DECREASED 1 0.0002
317 DISEASE COMPLICATION 1 0.0002
318 CELLULITIS 11 0.0002
319 BRAIN NEOPLASM 2 0.0002
320 RENAL FUNCTION TEST ABNORMAL 1 0.0002
321 ROSACEA 1 0.0002
322 PERFORMANCE STATUS DECREASED 1 0.0002
323 TUMOUR MARKER INCREASED 1 0.0002
324 FINGER DEFORMITY 1 0.0002
325 HAEMORRHOIDS 4 0.0002
326 HAEMATURIA 7 0.0002
327 BLADDER CANCER 12 0.0002
328 HOSPICE CARE 2 0.0002
329 DERMATITIS EXFOLIATIVE 1 0.0002
330 TOE AMPUTATION 1 0.0002
331 DYSLIPIDAEMIA 1 0.0002
332 BLINDNESS 8 0.0002
333 TINNITUS 9 0.0002
334 HYPOPHAGIA 5 0.0002
335 MALIGNANT NEOPLASM PROGRESSION 20 0.0002
336 PARTIAL SEIZURES 1 0.0002
337 PRODUCT USE COMPLAINT 3 0.0002
338 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
339 CHEILITIS 1 0.0002
340 HYDROCEPHALUS 1 0.0002
341 METASTASES TO BONE 3 0.0002
342 NONSPECIFIC REACTION 1 0.0002
343 ASTHENOPIA 1 0.0002
344 NEPHROPATHY TOXIC 2 0.0002
345 HYPONATRAEMIA 10 0.0002
346 EYE INFECTION 2 0.0002
347 INTERNAL HAEMORRHAGE 2 0.0002
348 SKIN ATROPHY 1 0.0002
349 METASTASES TO LUNG 2 0.0002
350 MADAROSIS 2 0.0002
351 METABOLIC DISORDER 1 0.0002
352 ELECTROLYTE IMBALANCE 2 0.0002
353 ECZEMA 9 0.0002
354 SKIN WARM 1 0.0002
355 PERIPHERAL SENSORY NEUROPATHY 1 0.0002
356 CATARACT OPERATION 1 0.0002
357 THIRST 3 0.0002
358 MACULAR DEGENERATION 2 0.0002
359 TYPE 1 DIABETES MELLITUS 1 0.0002
360 GANGRENE 1 0.0002
361 SKIN EXFOLIATION 14 0.0002
362 SPINAL OPERATION 2 0.0002
363 CHOLANGITIS 1 0.0002
364 ILEUS 2 0.0002
365 PHOTOPHOBIA 3 0.0002
366 DECREASED APPETITE 37 0.0002
367 BLOOD URINE PRESENT 3 0.0002
368 FOREIGN BODY SENSATION IN EYES 1 0.0002
369 HEPATIC CYTOLYSIS 2 0.0002
370 WHITE BLOOD CELL COUNT ABNORMAL 1 0.0002
371 HEPATITIS 4 0.0002
372 PROCTALGIA 1 0.0002
373 DIARRHOEA 100 0.0002
374 TENDON DISORDER 1 0.0002
375 ATRIOVENTRICULAR BLOCK COMPLETE 1 0.0001
376 COLITIS ISCHAEMIC 1 0.0001
377 BLOOD BILIRUBIN INCREASED 4 0.0001
378 ALOPECIA 29 0.0001
379 EPISTAXIS 11 0.0001
380 CENTRAL NERVOUS SYSTEM LESION 2 0.0001
381 HOSPITALISATION 22 0.0001
382 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
383 HYPOXIA 5 0.0001
384 PULMONARY TOXICITY 1 0.0001
385 THERMAL BURN 1 0.0001
386 EATING DISORDER 3 0.0001
387 PARAESTHESIA ORAL 2 0.0001
388 FAECES DISCOLOURED 3 0.0001
389 LIVER FUNCTION TEST ABNORMAL 4 0.0001
390 ORAL DISORDER 1 0.0001
391 BLINDNESS TRANSIENT 1 0.0001
392 LIVER DISORDER 6 0.0001
393 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
394 STEVENS-JOHNSON SYNDROME 3 0.0001
395 HAEMORRHAGE INTRACRANIAL 2 0.0001
396 KETOACIDOSIS 1 0.0001
397 HYDRONEPHROSIS 1 0.0001
398 HEPATIC FAILURE 4 0.0001
399 INTESTINAL OBSTRUCTION 5 0.0001
400 PEMPHIGOID 1 0.0001
401 COLITIS 5 0.0001
402 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
403 RENAL IMPAIRMENT 11 0.0001
404 THYROID DISORDER 2 0.0001
405 VISUAL IMPAIRMENT 16 0.0001
406 DYSPHAGIA 12 0.0001
407 NASAL DISCOMFORT 1 0.0001
408 PNEUMOTHORAX 2 0.0001
409 GINGIVAL PAIN 1 0.0001
410 BLISTER 7 0.0001
411 VISION BLURRED 17 0.0001
412 DEEP VEIN THROMBOSIS 8 0.0001
413 SHOCK HAEMORRHAGIC 1 0.0001
414 DECUBITUS ULCER 1 0.0001
415 HICCUPS 1 0.0001
416 HAIR DISORDER 1 0.0001
417 ACUTE CORONARY SYNDROME 1 0.0001
418 HEMIPLEGIA 1 0.0001
419 URINARY RETENTION 4 0.0001
420 NEOPLASM MALIGNANT 8 0.0001
421 PAIN IN EXTREMITY 35 0.0001
422 OFF LABEL USE 104 0.0001
423 SENSATION OF FOREIGN BODY 1 0.0001
424 HAEMATEMESIS 3 0.0001
425 URINARY TRACT INFECTION 20 0.0001
426 DRUG RESISTANCE 3 0.0001
427 SEPSIS 13 0.0001
428 SKIN HYPERPIGMENTATION 1 0.0001
429 SKIN ULCER 3 0.0001
430 BLOOD MAGNESIUM DECREASED 1 0.0001
431 PULMONARY EMBOLISM 11 0.0001
432 PYELONEPHRITIS 1 0.0001
433 BLOOD CALCIUM INCREASED 1 0.0001
434 GRIP STRENGTH DECREASED 1 0.0001
435 ANAL INCONTINENCE 1 0.0001
436 OROPHARYNGEAL DISCOMFORT 1 0.0001
437 OPTIC NEURITIS 1 0.0001
438 UROSEPSIS 1 0.0001
439 CONJUNCTIVITIS 2 0.0001
440 DYSGEUSIA 8 0.0001
441 EYE SWELLING 4 0.0001
442 WOUND 3 0.0001
443 HEPATIC FUNCTION ABNORMAL 4 0.0001
444 NEPHROPATHY 1 0.0001
445 MIDDLE INSOMNIA 2 0.0001
446 COGNITIVE DISORDER 5 0.0001
447 BLOOD SODIUM DECREASED 2 0.0001
448 FRACTURE 2 0.0001
449 MUSCULOSKELETAL DISORDER 2 0.0001
450 CHOLESTASIS 2 0.0001
451 ACUTE RESPIRATORY FAILURE 2 0.0001
452 DRUG INTOLERANCE 10 0.0001
453 PHARYNGEAL SWELLING 1 0.0001
454 WEIGHT DECREASED 28 0.0001
455 BRAIN INJURY 1 0.0001
456 EYELID PTOSIS 1 0.0001
457 DEHYDRATION 13 0.0001
458 EAR DISCOMFORT 1 0.0001
459 TEMPERATURE INTOLERANCE 1 0.0001
460 TOOTH LOSS 2 0.0001
461 CONSTIPATION 21 0.0001
462 TENDERNESS 1 0.0001
463 DRUG-INDUCED LIVER INJURY 3 0.0001
464 DERMATITIS 2 0.0001
465 TRANSFUSION 1 0.0001
466 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
467 FULL BLOOD COUNT ABNORMAL 1 0.0001
468 SUDDEN DEATH 1 0.0001
469 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
470 BREAST CANCER METASTATIC 1 0.0001
471 DECREASED ACTIVITY 1 0.0001
472 BLOOD CREATININE INCREASED 6 0.0001
473 PRODUCT DISPENSING ERROR 2 0.0001
474 OESOPHAGITIS 1 0.0001
475 TREATMENT NONCOMPLIANCE 5 0.0001
476 RASH MACULO-PAPULAR 2 0.0001
477 GLOSSODYNIA 2 0.0001
478 EYE PRURITUS 3 0.0001
479 OCULAR DISCOMFORT 1 0.0001
480 FISTULA 1 0.0001
481 CHROMATURIA 2 0.0001
482 HEPATIC ENZYME INCREASED 6 0.0001
483 MICTURITION URGENCY 1 0.0001
484 GASTRIC HAEMORRHAGE 1 0.0001
485 OROPHARYNGEAL PAIN 8 0.0001
486 NEOPLASM PROGRESSION 3 0.0001
487 VASCULITIS 1 0.0001
488 PRODUCT USE IN UNAPPROVED INDICATION 21 0.0001
489 COVID-19 PNEUMONIA 1 0.0001
490 BACTERAEMIA 1 0.0001
491 CHOLECYSTITIS 1 0.0001
492 POLYNEUROPATHY 1 0.0001
493 MENTAL IMPAIRMENT 2 0.0001
494 CYTOPENIA 1 0.0001
495 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
496 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
497 SMALL INTESTINAL OBSTRUCTION 1 0.0001
498 PHARYNGITIS 1 0.0001
499 TOOTH EXTRACTION 1 0.0001
500 ANAEMIA 15 0.0001
501 INTRAOCULAR PRESSURE INCREASED 1 0.0001
502 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
503 NODULE 1 0.0001
504 BEDRIDDEN 1 0.0001
505 GASTRITIS 2 0.0001
506 PULMONARY CONGESTION 1 0.0001
507 HAIR TEXTURE ABNORMAL 1 0.0001
508 MALIGNANT MELANOMA 1 0.0001
509 QUALITY OF LIFE DECREASED 1 0.0001
510 SINUS CONGESTION 1 0.0001
511 THROAT TIGHTNESS 2 0.0001
512 SKIN LESION 2 0.0001
513 PERIPHERAL COLDNESS 1 0.0001
514 RESPIRATORY DISTRESS 2 0.0001
515 MENTAL STATUS CHANGES 2 0.0001
516 HYPOMAGNESAEMIA 1 0.0001
517 BLOOD TEST ABNORMAL 1 0.0001
518 SKIN REACTION 1 0.0001
519 EYE PAIN 4 0.0001
520 HEPATOCELLULAR INJURY 1 0.0001
521 DIALYSIS 1 0.0001
522 THERAPY INTERRUPTED 5 0.0001
523 PRODUCT USE ISSUE 13 0.0001
524 SEPTIC SHOCK 3 0.0001
525 HYPOKINESIA 1 0.0001
526 DYSPHONIA 4 0.0001
527 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
528 FATIGUE 53 0.0001
529 ASCITES 2 0.0001
530 ILLNESS 7 0.0001
531 CARDIOMYOPATHY 1 0.0001
532 HYPOAESTHESIA ORAL 1 0.0001
533 PLEURAL EFFUSION 4 0.0001
534 ACUTE KIDNEY INJURY 10 0.0001
535 SKIN DISCOLOURATION 3 0.0001
536 MUSCULOSKELETAL CHEST PAIN 1 0.0001
537 DELUSION 1 0.0001
538 ASTHENIA 24 0.0001
539 BRAIN FOG 1 0.0001
540 SCIATICA 1 0.0001
541 ABSCESS 1 0.0001
542 HYPOTHYROIDISM 2 0.0001
543 SENSORY DISTURBANCE 1 0.0001
544 BLOOD POTASSIUM INCREASED 1 0.0001
545 STAPHYLOCOCCAL INFECTION 2 0.0001
546 PHOTOSENSITIVITY REACTION 1 0.0001
547 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
548 EXPIRED PRODUCT ADMINISTERED 2 0.0001
549 LIP SWELLING 2 0.0001
550 HEMIPARESIS 1 0.0001
551 NEUROTOXICITY 1 0.0001
552 PANCREATITIS 3 0.0001
553 COLD SWEAT 1 0.0001
554 GASTROINTESTINAL DISORDER 5 0.0001
555 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 10 0.0001
556 BONE DISORDER 1 0.0001
557 HYPOTENSION 11 0.0001
558 PRODUCT DOSE OMISSION ISSUE 16 0.0001
559 HAEMATOCHEZIA 3 0.0001
560 MEDICATION ERROR 3 0.0001
561 THROMBOCYTOPENIA 6 0.0001
562 PROTEINURIA 1 0.0001
563 LOWER LIMB FRACTURE 1 0.0001
564 GLAUCOMA 1 0.0001
565 HERNIA 1 0.0001
566 ERUCTATION 1 0.0001
567 EAR PAIN 1 0.0001
568 KIDNEY INFECTION 1 0.0001
569 PRODUCT PHYSICAL ISSUE 1 0.0000
570 PERITONITIS 1 0.0000
571 PULMONARY HYPERTENSION 1 0.0000
572 OSTEOARTHRITIS 2 0.0000
573 MELAENA 1 0.0000
574 RENAL FAILURE 6 0.0000
575 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
576 PULMONARY OEDEMA 2 0.0000
577 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
578 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
579 THROAT IRRITATION 2 0.0000
580 PRODUCT AVAILABILITY ISSUE 1 0.0000
581 ERYTHEMA 9 0.0000
582 SHOCK 1 0.0000
583 SEIZURE 5 0.0000
584 PERICARDIAL EFFUSION 1 0.0000
585 ABDOMINAL PAIN 10 0.0000
586 SWELLING 4 0.0000
587 OCULAR HYPERAEMIA 2 0.0000
588 LOCALISED INFECTION 1 0.0000
589 RESPIRATORY FAILURE 3 0.0000
590 CEREBRAL INFARCTION 1 0.0000
591 LIVER INJURY 1 0.0000
592 ENCEPHALOPATHY 1 0.0000
593 VOMITING 19 0.0000
594 HYPOAESTHESIA 6 0.0000
595 PNEUMONIA ASPIRATION 1 0.0000
596 GASTRIC CANCER 1 0.0000
597 CARDIOVASCULAR DISORDER 1 0.0000
598 ERECTILE DYSFUNCTION 1 0.0000
599 ANAPHYLACTIC SHOCK 1 0.0000
600 MALAISE 17 0.0000
601 MUSCLE SPASMS 7 0.0000
602 JOINT STIFFNESS 1 0.0000
603 NAUSEA 30 0.0000
604 DEPRESSED MOOD 2 0.0000
605 THROMBOSIS 3 0.0000
606 JAUNDICE 1 0.0000
607 PAIN OF SKIN 1 0.0000
608 CONFUSIONAL STATE 6 0.0000
609 LIMB INJURY 1 0.0000
610 RASH 16 0.0000
611 DEMENTIA 1 0.0000
612 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
613 MYALGIA 6 0.0000
614 FLATULENCE 2 0.0000
615 MUSCULAR WEAKNESS 4 0.0000
616 HERPES ZOSTER 2 0.0000
617 LETHARGY 2 0.0000
618 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
619 PANCREATIC CARCINOMA 1 0.0000
620 NASAL CONGESTION 2 0.0000
621 ACUTE MYOCARDIAL INFARCTION 1 0.0000
622 URINARY INCONTINENCE 1 0.0000
623 RESPIRATORY DISORDER 1 0.0000
624 APHASIA 1 0.0000
625 CONDITION AGGRAVATED 10 0.0000
626 DISCOMFORT 2 0.0000
627 EPILEPSY 1 0.0000
628 NERVOUS SYSTEM DISORDER 1 0.0000
629 RHINORRHOEA 2 0.0000
630 PNEUMONIA 10 0.0000
631 BLOOD PRESSURE DECREASED 2 0.0000
632 FUNGAL INFECTION 1 0.0000
633 GAIT INABILITY 1 0.0000
634 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
635 CEREBROVASCULAR ACCIDENT 5 0.0000
636 HAEMORRHAGE 3 0.0000
637 PRURITUS 11 0.0000
638 RASH MACULAR 1 0.0000
639 LYMPHADENOPATHY 1 0.0000
640 DIZZINESS 14 0.0000
641 DRUG EFFECT INCOMPLETE 1 0.0000
642 HYPERGLYCAEMIA 1 0.0000
643 ACCIDENTAL OVERDOSE 1 0.0000
644 DYSURIA 1 0.0000
645 DRUG INEFFECTIVE 35 0.0000
646 DYSPNOEA EXERTIONAL 1 0.0000
647 ARTHRALGIA 11 0.0000
648 UNEVALUABLE EVENT 2 0.0000
649 PAIN 16 0.0000
650 PERIPHERAL SWELLING 4 0.0000
651 PLASMA CELL MYELOMA 1 0.0000
652 PARAESTHESIA 4 0.0000
653 FEELING ABNORMAL 6 0.0000
654 CARDIAC FAILURE 2 0.0000
655 EXTRA DOSE ADMINISTERED 1 0.0000
656 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
657 CARDIO-RESPIRATORY ARREST 1 0.0000
658 TOXICITY TO VARIOUS AGENTS 4 0.0000
659 LOSS OF CONSCIOUSNESS 3 0.0000
660 RECTAL HAEMORRHAGE 1 0.0000
661 HYPOACUSIS 1 0.0000
662 BALANCE DISORDER 2 0.0000
663 DEVICE DISLOCATION 1 0.0000
664 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
665 COLITIS ULCERATIVE 1 0.0000
666 NEPHROLITHIASIS 1 0.0000
667 BACK PAIN 5 0.0000
668 RENAL DISORDER 1 0.0000
669 CARDIAC DISORDER 2 0.0000
670 ARRHYTHMIA 1 0.0000
671 COMA 1 0.0000
672 PRODUCTIVE COUGH 1 0.0000
673 RASH ERYTHEMATOUS 1 0.0000
674 GAIT DISTURBANCE 4 0.0000
675 CONTUSION 2 0.0000
676 INTERSTITIAL LUNG DISEASE 1 0.0000
677 HYPOGLYCAEMIA 1 0.0000
678 FLUSHING 2 0.0000
679 FLUID RETENTION 1 0.0000
680 ABDOMINAL PAIN UPPER 4 0.0000
681 MUSCULOSKELETAL PAIN 1 0.0000
682 SPEECH DISORDER 1 0.0000
683 DERMATITIS ATOPIC 1 0.0000
684 INSOMNIA 5 0.0000
685 PLATELET COUNT DECREASED 2 0.0000
686 RASH PRURITIC 1 0.0000
687 WHITE BLOOD CELL COUNT DECREASED 2 0.0000
688 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
689 ARTHROPATHY 1 0.0000
690 NECK PAIN 1 0.0000
691 ABDOMINAL DISCOMFORT 3 0.0000
692 DYSPNOEA 10 0.0000
693 INCORRECT DOSE ADMINISTERED 4 0.0000
694 BONE PAIN 1 0.0000
695 SURGERY 1 0.0000
696 IRRITABILITY 1 0.0000
697 THERAPEUTIC RESPONSE DECREASED 1 0.0000
698 OEDEMA PERIPHERAL 2 0.0000
699 VERTIGO 1 0.0000
700 FEELING HOT 1 0.0000
701 FALL 5 0.0000
702 SOMNOLENCE 3 0.0000
703 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
704 BURNING SENSATION 1 0.0000
705 SLEEP DISORDER 1 0.0000
706 OVERDOSE 3 0.0000
707 INFECTION 2 0.0000
708 CHRONIC KIDNEY DISEASE 1 0.0000
709 DIABETES MELLITUS 1 0.0000
710 HEADACHE 8 0.0000
711 PROSTATE CANCER 1 0.0000
712 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
713 MYOCARDIAL INFARCTION 2 0.0000
714 PRODUCT STORAGE ERROR 1 0.0000
715 INTENTIONAL PRODUCT MISUSE 1 0.0000
716 MUSCULOSKELETAL STIFFNESS 1 0.0000
717 COVID-19 2 0.0000
718 COUGH 3 0.0000
719 ATRIAL FIBRILLATION 1 0.0000
720 DYSPEPSIA 1 0.0000
721 SYNCOPE 1 0.0000
722 CHEST DISCOMFORT 1 0.0000
723 HAEMOGLOBIN DECREASED 1 0.0000
724 ABDOMINAL DISTENSION 1 0.0000
725 HYPERTENSION 2 0.0000
726 INFLUENZA 1 0.0000
727 RHEUMATOID ARTHRITIS 1 0.0000
728 PYREXIA 3 0.0000
729 JOINT SWELLING 1 0.0000
730 HYPERHIDROSIS 1 0.0000
731 PRODUCT QUALITY ISSUE 1 0.0000
732 DRUG INTERACTION 1 0.0000
733 NO ADVERSE EVENT 1 0.0000
734 NASOPHARYNGITIS 1 0.0000
735 CHEST PAIN 1 0.0000
736 HYPERSENSITIVITY 1 0.0000
737 WEIGHT INCREASED 1 0.0000
738 DEPRESSION 1 0.0000
739 ANXIETY 1 0.0000